A Model to Investigate the Feasibility of FDG as a Surrogate Marker of Hypoxia

doi 10.1109/isbi.2007.356908
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IEEE

Related search

FDG Uptake, a Surrogate of Tumour Hypoxia?

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2008English

The Bee as a Model to Investigate Brain and Behavioural Asymmetries

Insects
Insect Science
2014English

Tumor pO2 as a Surrogate Marker to Identify Therapeutic Window During Metronomic Chemotherapy of 9L Gliomas

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2011English

Fluoromisonidazole. A Metabolic Marker of Myocyte Hypoxia

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1990English

Unique Cyanide Adduct in Human Serum Albumin: Potential as a Surrogate Exposure Marker

Chemical Research in Toxicology
MedicineToxicology
2011English

RAD51 as a Potential Surrogate Marker for DNA Repair Capacity in Solid Malignancies

International Journal of Cancer
Cancer ResearchOncology
2017English

Skin Thickness Score as a Surrogate Marker of Organ Involvements in Systemic Sclerosis: A Retrospective Observational Study

Arthritis Research & Therapy
2019English

Osteitic Bone: A Surrogate Marker of Eosinophilia in Chronic Rhinosinusitis

Rhinology
MedicineOtorhinolaryngology
2012English

Plasma Anti-FXa Level as a Surrogate Marker of the Adequacy of Thromboprophylaxis in Critically Ill Patients: A Systematic Review

Thrombosis Research
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy